188 related articles for article (PubMed ID: 30806242)
1. Does TNF Promote or Restrain Osteoclastogenesis and Inflammatory Bone Resorption?
Zhao B
Crit Rev Immunol; 2018; 38(4):253-261. PubMed ID: 30806242
[TBL] [Abstract][Full Text] [Related]
2. Intrinsic Restriction of TNF-Mediated Inflammatory Osteoclastogenesis and Bone Resorption.
Zhao B
Front Endocrinol (Lausanne); 2020; 11():583561. PubMed ID: 33133025
[TBL] [Abstract][Full Text] [Related]
3. RANK-Independent Osteoclast Formation and Bone Erosion in Inflammatory Arthritis.
O'Brien W; Fissel BM; Maeda Y; Yan J; Ge X; Gravallese EM; Aliprantis AO; Charles JF
Arthritis Rheumatol; 2016 Dec; 68(12):2889-2900. PubMed ID: 27563728
[TBL] [Abstract][Full Text] [Related]
4. TNF-induced osteoclastogenesis and inflammatory bone resorption are inhibited by transcription factor RBP-J.
Zhao B; Grimes SN; Li S; Hu X; Ivashkiv LB
J Exp Med; 2012 Feb; 209(2):319-34. PubMed ID: 22249448
[TBL] [Abstract][Full Text] [Related]
5. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
Kim HJ; Chang EJ; Kim HM; Lee SB; Kim HD; Su Kim G; Kim HH
Free Radic Biol Med; 2006 May; 40(9):1483-93. PubMed ID: 16632109
[TBL] [Abstract][Full Text] [Related]
6. RBP-J-Regulated miR-182 Promotes TNF-α-Induced Osteoclastogenesis.
Miller CH; Smith SM; Elguindy M; Zhang T; Xiang JZ; Hu X; Ivashkiv LB; Zhao B
J Immunol; 2016 Jun; 196(12):4977-86. PubMed ID: 27183593
[TBL] [Abstract][Full Text] [Related]
7. Jagged1 Acts as an RBP-J Target and Feedback Suppresses TNF-Mediated Inflammatory Osteoclastogenesis.
Ng C; Qin Y; Xia Y; Hu X; Zhao B
J Immunol; 2023 Nov; 211(9):1340-1347. PubMed ID: 37756541
[TBL] [Abstract][Full Text] [Related]
8. Sanguiin H-6, a constituent of Rubus parvifolius L., inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis and bone resorption in vitro and prevents tumor necrosis factor-α-induced osteoclast formation in vivo.
Sakai E; Aoki Y; Yoshimatsu M; Nishishita K; Iwatake M; Fukuma Y; Okamoto K; Tanaka T; Tsukuba T
Phytomedicine; 2016 Jul; 23(8):828-37. PubMed ID: 27288918
[TBL] [Abstract][Full Text] [Related]
9. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
Valverde P; Tu Q; Chen J
J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
[TBL] [Abstract][Full Text] [Related]
10. Non-Canonical (RANKL-Independent) Pathways of Osteoclast Differentiation and Their Role in Musculoskeletal Diseases.
Sabokbar A; Mahoney DJ; Hemingway F; Athanasou NA
Clin Rev Allergy Immunol; 2016 Aug; 51(1):16-26. PubMed ID: 26578261
[TBL] [Abstract][Full Text] [Related]
11. New Insights for RANKL as a Proinflammatory Modulator in Modeled Inflammatory Arthritis.
Papadaki M; Rinotas V; Violitzi F; Thireou T; Panayotou G; Samiotaki M; Douni E
Front Immunol; 2019; 10():97. PubMed ID: 30804932
[TBL] [Abstract][Full Text] [Related]
12. Def6 Restrains Osteoclastogenesis and Inflammatory Bone Resorption.
Binder N; Miller C; Yoshida M; Inoue K; Nakano S; Hu X; Ivashkiv LB; Schett G; Pernis A; Goldring SR; Ross FP; Zhao B
J Immunol; 2017 May; 198(9):3436-3447. PubMed ID: 28314855
[TBL] [Abstract][Full Text] [Related]
13. IFN-γ directly inhibits TNF-α-induced osteoclastogenesis in vitro and in vivo and induces apoptosis mediated by Fas/Fas ligand interactions.
Kohara H; Kitaura H; Fujimura Y; Yoshimatsu M; Morita Y; Eguchi T; Masuyama R; Yoshida N
Immunol Lett; 2011 Jun; 137(1-2):53-61. PubMed ID: 21338623
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-4 directly inhibits tumor necrosis factor-alpha-mediated osteoclast formation in mouse bone marrow macrophages.
Kitaura H; Nagata N; Fujimura Y; Hotokezaka H; Tatamiya M; Nakao N; Yoshida N; Nakayama K
Immunol Lett; 2003 Sep; 88(3):193-8. PubMed ID: 12941478
[TBL] [Abstract][Full Text] [Related]
15. TGFβ reprograms TNF stimulation of macrophages towards a non-canonical pathway driving inflammatory osteoclastogenesis.
Xia Y; Inoue K; Du Y; Baker SJ; Reddy EP; Greenblatt MB; Zhao B
Nat Commun; 2022 Jul; 13(1):3920. PubMed ID: 35798734
[TBL] [Abstract][Full Text] [Related]
16. [Regulatory mechanism of bone resorption: roles of bone remodeling-regulatory cytokines 'osteokines' in osteoclast differentiation and function].
Kobayashi Y; Takahashi N
Nihon Rinsho; 2003 Feb; 61(2):200-6. PubMed ID: 12638208
[TBL] [Abstract][Full Text] [Related]
17. TNF and Bone Remodeling.
Zhao B
Curr Osteoporos Rep; 2017 Jun; 15(3):126-134. PubMed ID: 28477234
[TBL] [Abstract][Full Text] [Related]
18. Toll-Like Receptor 2 Stimulation of Osteoblasts Mediates Staphylococcus Aureus Induced Bone Resorption and Osteoclastogenesis through Enhanced RANKL.
Kassem A; Lindholm C; Lerner UH
PLoS One; 2016; 11(6):e0156708. PubMed ID: 27311019
[TBL] [Abstract][Full Text] [Related]
19. Effect of tumor necrosis factor α on ability of SHED to promote osteoclastogenesis during physiological root resorption.
Wang C; Wang Y; Liu N; Cai C; Xu L
Biomed Pharmacother; 2019 Jun; 114():108803. PubMed ID: 30951949
[TBL] [Abstract][Full Text] [Related]
20. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]